{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:27:22Z","timestamp":1793636842547,"version":"4.5.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.thromres.2026.109893","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:10:06Z","timestamp":1792451406000},"page":"109893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Apixaban for thromboprophylaxis in paediatric cardiology patients: Real-world data from a single institution"],"prefix":"10.1016","volume":"266","author":[{"given":"Alessandra","family":"Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitendu","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Albisetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2026.109893_bb0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40119-021-00228-4","article-title":"Thrombosis prevention and anticoagulation management in the pediatric patient with congenital heart disease","volume":"10","author":"Abdelghani","year":"2021","journal-title":"Cardiol. Ther."},{"key":"10.1016\/j.thromres.2026.109893_bb0010","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/PCC.0000000000000623","article-title":"Pediatric Cardiac Intensive Care Society 2014 consensus statement: pharmacotherapies in cardiac critical care anticoagulation and thrombolysis","volume":"17","author":"Giglia","year":"2016","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.thromres.2026.109893_bb0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/BPB.0000000000000053","article-title":"Risk factors for venous thromboembolism in hospitalized children and adolescents: a systemic review and pooled analysis","volume":"23","author":"Kim","year":"2014","journal-title":"J. Pediatr. Orthop. B"},{"key":"10.1016\/j.thromres.2026.109893_bb0020","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1161\/CIRCULATIONAHA.110.006304","article-title":"Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery","volume":"124","author":"Manlhiot","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2026.109893_bb0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MBC.0b013e3282fe73b1","article-title":"Thrombosis in children with cardiac pathology: analysis of acquired and inherited risk factors","volume":"19","author":"Alioglu","year":"2008","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2026.109893_bb0030","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0003-4975(01)02472-9","article-title":"Thrombus formation after the Fontan operation","volume":"71","author":"Coon","year":"2001","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.thromres.2026.109893_bb0035","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s00431-025-06351-x","article-title":"European thromboprophylaxis practice amongst paediatric cardiology units","volume":"184","author":"Ryan","year":"2025","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.thromres.2026.109893_bb0040","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1161\/01.cir.0000436140.77832.7a","article-title":"Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association","volume":"128","author":"Giglia","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2026.109893_bb0045","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2026.109893_bb0050","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(20)30368-9","article-title":"Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b\/3, non-inferiority trial","volume":"8","author":"Halton","year":"2021","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2026.109893_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.021765","article-title":"Thromboprophylaxis for children post-Fontan procedure: insights from the UNIVERSE study","volume":"10","author":"McCrindle","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2026.109893_bb0060","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jacc.2023.10.010","article-title":"Apixaban for prevention of thromboembolism in pediatric heart disease","volume":"82","author":"Payne","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2026.109893_bb0065","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2022.09.031","article-title":"Edoxaban for thromboembolism prevention in pediatric patients with cardiac disease","volume":"80","author":"Portman","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2026.109893_bb0070","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jtha.2023.03.005","article-title":"Real-world use of apixaban for the treatment and prevention of thrombosis in children with cardiac disease","volume":"21","author":"VanderPluym","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109893_bb0075","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.thromres.2026.109893_bb0080","article-title":"Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis","volume":"0","author":"Whitworth","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109893_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.thromres.2017.12.009","article-title":"Increasing rates of thrombosis in children with congenital heart disease undergoing cardiac surgery","volume":"162","author":"Silvey","year":"2018","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2026.109893_bb0090","article-title":"Real-world use and outcomes of apixaban for early post-surgical Fontan thromboprophylaxis","author":"Adkins","year":"2024","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.thromres.2026.109893_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14632","article-title":"Use of apixaban in children awaiting heart transplantation","volume":"28","author":"Benvenuto","year":"2024","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.thromres.2026.109893_bb0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/a-2486-6735","article-title":"The use of DOACs in pediatrics: current therapeutic and prophylactic indications, cardiac indications, and real-world evidence-a review","volume":"45","author":"Bosch","year":"2025","journal-title":"Hamostaseologie"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826003129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826003129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:46:35Z","timestamp":1793634395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826003129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"alternative-id":["S0049384826003129"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109893","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apixaban for thromboprophylaxis in paediatric cardiology patients: Real-world data from a single institution","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109893"}}